These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advances in first-line treatment of chronic lymphocytic leukemia: current recommendations on management and first-line treatment by the German CLL Study Group (GCLLSG). Cramer P; Langerbeins P; Eichhorst B; Hallek M Eur J Haematol; 2016 Jan; 96(1):9-18. PubMed ID: 26332019 [TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. Hallek M Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509 [TBL] [Abstract][Full Text] [Related]
5. [Current diagnosis and treatment of chronic lymphocytic leukaemia]. Cramer P; von Tresckow J; Eichhorst B; Hallek M Dtsch Med Wochenschr; 2020 Aug; 145(16):1139-1144. PubMed ID: 32791549 [TBL] [Abstract][Full Text] [Related]
6. Prognostic markers and standard management of chronic lymphocytic leukemia. Stilgenbauer S Hematology Am Soc Hematol Educ Program; 2015; 2015():368-77. PubMed ID: 26637745 [TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Hallek M Am J Hematol; 2017 Sep; 92(9):946-965. PubMed ID: 28782884 [TBL] [Abstract][Full Text] [Related]
13. [Chronic lymphatic leukemia]. Bergmann M; Wendtner CM Dtsch Med Wochenschr; 2015 Apr; 140(7):479-82. PubMed ID: 25826029 [TBL] [Abstract][Full Text] [Related]
14. Evolving Strategies for the Treatment of Chronic Lymphocytic Leukemia in the Upfront Setting. Bachow SH; Lamanna N Curr Hematol Malig Rep; 2016 Feb; 11(1):61-70. PubMed ID: 26951237 [TBL] [Abstract][Full Text] [Related]
15. Targeted therapies for CLL: Practical issues with the changing treatment paradigm. Jain N; O'Brien S Blood Rev; 2016 May; 30(3):233-44. PubMed ID: 26776345 [TBL] [Abstract][Full Text] [Related]
16. Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia: Harnessing the Power of New Monoclonal Antibodies in Combination With Ibrutinib. Cramer P; Langerbeins P; Hallek M Cancer J; 2016; 22(1):62-6. PubMed ID: 26841018 [TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment. Hallek M Am J Hematol; 2013 Sep; 88(9):803-16. PubMed ID: 23720127 [TBL] [Abstract][Full Text] [Related]
19. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia. Wendtner CM; Gregor M Leuk Lymphoma; 2018 Feb; 59(2):300-310. PubMed ID: 28565930 [TBL] [Abstract][Full Text] [Related]
20. Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia. Robak T; Blonski JZ; Robak P Semin Oncol; 2016 Apr; 43(2):280-90. PubMed ID: 27040707 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]